Clinical Trial

Probiotic Intervention for People With Multiple Sclerosis

Completed
View on ClinicalTrials.gov →
Summary
The goal of this single-arm, mixed methods trial is to learn if it is feasible and acceptable to take a probiotic for 12-weeks in people with Multiple Sclerosis. The main question\[s\] it aims to answer \[is/are\]: * Is it feasible and acceptable for people with MS to take a probiotic for 12-weeks? * Explore impact on health outcomes? Participants will. * Drink 70ml probiotic drink daily as prescribed for 12-weeks. * All data collection will be done remotely. * Before and after 12-weeks participants will complete an online questionnaire (Acceptability, lifestyle behaviour, symptoms, quality of life). * Provide a stool sample to analyse microbiome changes. * Take a short online cognitive test. * Participate in a focus group.
Trial Details
NCT Number NCT07304713
Lead Sponsor Sheffield Hallam University
Conditions Multiple Sclerosis
Enrollment 29 participants
Start Date 2023-06-20
Primary Completion 2023-11-24 (estimated)
Study Completion 2023-11-24 (estimated)
Updated on ClinicalTrials.gov 2025-12-26